Match!
Mehmet Ali Özcan
Dokuz Eylül University
EndocrinologyPathologyImmunologyDiabetes mellitusMedicine
122Publications
15H-index
568Citations
What is this?
Publications 132
Newest
#2Ilknur KozanogluH-Index: 10
Last. Ali UnalH-Index: 20
view all 11 authors...
Source
#1Pau Montesinos (ISCIII: Carlos III Health Institute)H-Index: 13
#1Pau Montesinos (ISCIII: Carlos III Health Institute)H-Index: 24
Last. Vadim DoroninH-Index: 1
view all 25 authors...
Talacotuzumab, a humanized anti-CD123 monoclonal antibody, was evaluated in combination with decitabine in elderly patients with acute myeloid leukemia (AML) not eligible for intensive chemotherapy. A multicenter, phase 2/3 study was initiated to determine the recommended phase 2 dose (RP2D) of talacotuzumab (Part A) followed by an open-label, randomized comparison of talacotuzumab in combination with decitabine versus decitabine alone to assess achievement of complete response (CR) and overall ...
1 CitationsSource
Last. Bulent UndarH-Index: 11
view all 11 authors...
Source
#1Fatma Keklik Karadag (Ege University)
#2Mustafa Nuri Yenerel (Istanbul University)H-Index: 7
Last. Fahri Sahin (Ege University)H-Index: 10
view all 37 authors...
Source
#1Anil Tombak (Mersin University)H-Index: 6
Last. Burhan Ferhanoglu (Koç University)H-Index: 14
view all 43 authors...
Source
Source
Source
Last. Inci Alacacioglu (Dokuz Eylül University)H-Index: 8
view all 11 authors...
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. MATERIALS AND METHODS: We retrospectively examined the PLR, NLR, and MLR in a cohort of 186 newly diagnosed multiple myeloma (MM) patients. This study investigated the prognostic relevance of NLR, PLR, and MLR in MM patients. NLR, PLR, and MLR were ca...
Source
#2Celal AcarH-Index: 2
Last. Güner Hayri Özsan (Dokuz Eylül University)H-Index: 5
view all 13 authors...
Source
12345678910